Cancer of CervixEEWCCKABNCT05990270
The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief
A study testing education in people with Cancer of Cervix and HPV Infection, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).
Trial summary
Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief. Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control). Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cancer of Cervix, HPV Infection
- What is being tested?
- education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 102 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Aug 2023to 30 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- least literate, no communication problem women who agreed to participate in the study
Who cannot join
- literate are women who do not have communication problems (hearing impairment, visual impairment)
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kahramanmaraş ISU
Kahramanmaraş, K.Maraş, 46100
About this study
Official title: The Effect of Education Given to Women on Knowledge, Attitudes and Beliefs on Cervical Cancer
Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief.
Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).
Read the detailed description
Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief.
Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).
In the first stage, the researcher participants were informed about the purpose of the researcher and the questionnaire, and their consent was obtained for participation in the study.
In the second stage, pre-test data will be obtained with the face-to-face interview method of the research data and a questionnaire form. Cervical cancer education will be provided. (The training is in three sessions, each session will last 20-30 minutes. In the training; Cervical cancer, ppt presentation on HPV virus, question-answer method, female pelvic anatomy on the gynecological examination model, gynecological examination, how the Pap Test is done, and cervical cancer pathologies. will be explained )) After the training, the post-test data will be obtained by applying the questionnaire again.
- Conditions
- Cancer of Cervix, HPV Infection
- Being tested
- education
- Keywords
- Cervical cancer,, early diagnosis,, Pap smear,
- Medical subject headings
- Uterine Cervical Neoplasms, Papillomavirus Infections, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
educationBehavioural
Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.
| Study group | Role | What they receive |
|---|---|---|
| EXPERIMENTAL GROUP | Experimental | Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again. Receives: Behavioral: education |
| control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
First Measurement: Human Papilloma Virus (HPV) Knowledge Scale
ASSESSMENT OF WOMEN'S AWARENESS ON HPV
Measured: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
Second Measurement:Cervical Cancer and Pap-Smear Test Health Belief Model Scale
ASSESSMENT OF HEALTH BELIEFS
Measured: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2023
- Study start15 Aug 2023
- Primary completion30 Sep 2023
- Study completion30 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cancer of CervixStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Parallel Assignment
- Masking
- None (open label)
- Enrolment
- 102 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hatice Gul OZTAS, Kahramanmaras Sutcu Imam University
- Investigators
- HATİCE GÜL ÖZTAŞ, Study director, KahramanmaraşISU
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05990270
- Sponsor's protocol ID
- KahramanmaraşSIUU
- Acronym
- EEWCCKAB
- Status last verified
- Jul 2023
- First submitted
- 28 Jul 2023
- Last updated
- 24 Jun 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Gul Oztas H, Isik K. The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study. Public Health Nurs. 2025 Jan-Feb;42(1):363-373. doi: 10.1111/phn.13456. Epub 2024 Oct 17.
PubMed 39420668
Study at a glance
From the registry record, last updated by the sponsor on 24 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Education Given to Women on Knowledge, Attitudes and Beliefs on Cervical Cancer
- ClinicalTrials.gov ID
- NCT05990270
- Acronym / sponsor ID
- EEWCCKAB / KahramanmaraşSIUU
- Conditions
- Cancer of Cervix, HPV Infection
- Keywords
- Cervical cancer,, early diagnosis,, Pap smear,
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 102 participants (actual)
- Lead sponsor
- Kahramanmaras Sutcu Imam UniversityUniversity, hospital or other
- Study start
- 15 Aug 2023 (actual)
- Primary completion
- 30 Sep 2023 (actual)
- Study completion
- 30 Dec 2023 (actual)
- First posted
- 14 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief.
Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).
Detailed description
Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief.
Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).
In the first stage, the researcher participants were informed about the purpose of the researcher and the questionnaire, and their consent was obtained for participation in the study.
In the second stage, pre-test data will be obtained with the face-to-face interview method of the research data and a questionnaire form. Cervical cancer education will be provided. (The training is in three sessions, each session will last 20-30 minutes. In the training; Cervical cancer, ppt presentation on HPV virus, question-answer method, female pelvic anatomy on the gynecological examination model, gynecological examination, how the Pap Test is done, and cervical cancer pathologies. will be explained )) After the training, the post-test data will be obtained by applying the questionnaire again.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Parallel Assignment
| Arm | Type | Receives |
|---|---|---|
| EXPERIMENTAL GROUP | Experimental | Behavioral: educationCervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again. |
| control group | No intervention | – |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- least literate, no communication problem women who agreed to participate in the study
Key exclusion criteria (1 listed)
- literate are women who do not have communication problems (hearing impairment, visual impairment)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| educationCervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again. | Behavioural | EXPERIMENTAL GROUP |
Primary outcome
First Measurement: Human Papilloma Virus (HPV) Knowledge Scale
Time frame: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
ASSESSMENT OF WOMEN'S AWARENESS ON HPV
Second Measurement:Cervical Cancer and Pap-Smear Test Health Belief Model Scale
Time frame: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
ASSESSMENT OF HEALTH BELIEFS
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jun 2024.
- Derived from this study: PubMed 39420668Gul Oztas H, Isik K. The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study. Public Health Nurs. 2025 Jan-Feb;42(1):363-373. doi: 10.1111/phn.13456. Epub 2024 Oct 17.
- Individual participant dataSharing planned: No
Related trials for Cancer of Cervix
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
RecruitingPhase 3
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
RecruitingPhase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
Enrolling by invitationObservational study
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
Cervical Cancer Screening
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
HATİCE GÜL ÖZTAŞ study director
KahramanmaraşISU
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing education in people with Cancer of Cervix and HPV Infection, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
First Measurement: Human Papilloma Virus (HPV) Knowledge Scale (time frame: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05990270, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2024.